SCHEMBL30383611

SCHEMBL30383611

O=C(/C=C/c1ccc(O)c(O)c1)c1ccc(Cl)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ CXCL12 P48061 3/20 1.00
▸ SNCA P37840 2/20 0.76
▸ TERT O14746 1/20 0.76
▸ MAPT P10636 1/20 0.76
▸ DHODH Q02127 1/20 0.74
▸ CXCR4 P61073 1/20 0.70
▸ MAOB P27338 2/20 0.69
▸ MMP1 P03956 1/20 0.62
▸ MMP2 P08253 1/20 0.62
▸ MMP9 P14780 1/20 0.62
▸ MAOA P21397 1/20 0.62
▸ XDH P47989 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23951756 1.00 CXCL12 (1.00) CXCL12SNCATERTMAPTDHODH
SCHEMBL25221567 0.89 CXCL12 (0.80) CXCL12SNCATERTMAPTDHODH
SCHEMBL30384517 0.89 CXCL12 (0.80) CXCL12SNCATERTMAPTDHODH
SCHEMBL25209522 0.89 CXCL12 (0.80) CXCL12SNCATERTMAPTDHODH
SCHEMBL8768036 0.87 XDH (0.81) CXCL12SNCATERTMAPTXDH
SCHEMBL8768038 0.87 XDH (0.81) CXCL12SNCATERTMAPTXDH
SCHEMBL25193897 0.87 XDH (0.81) CXCL12SNCATERTMAPTXDH
SCHEMBL31233412 0.87 XDH (0.81) CXCL12SNCATERTMAPTXDH
SCHEMBL109015 0.86 SNCA (1.00) CXCL12SNCATERTMAPTXDH
SCHEMBL143710 0.86 SNCA (1.00) CXCL12SNCATERTMAPTXDH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4429763-A1 COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS Yewsavin, Inc. (US) 2024-09-18 — — EP disclosed
WO-2023086388-A1 COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS YewSavin, Inc. (US) 2023-05-19 — — WO disclosed
Send feedback